Food & Drink

disease
Flu vaccination effectiveness has ranged from 10-60% over the past 20 years. This compares with the 90+% effectiveness of the new COVID-19 vaccines. The reason for this is that national health agencies monitor a few thousand samples globally and then …
There was another update on President Trump’s COVID from Walter Reed and the medical team. Trump is now getting the steroid Dexamethasone. This was due to oxygen levels getting to around 94. The steroid Dexamethasone was given to patients in …
More public mask-wearing is very important to curbing the spread of COVID-19, but is 80% of the population complying with mask-wearing good enough? Above the picture shows Mask compliance but no seatbelt. Getting to Hong Kong levels of 99% mask-wearing …
Antibody levels found in recovered COVID-19 patients fell sharply in 2-3 months after infection for both symptomatic and asymptomatic patients, according to a Chinese study published in Nature Medicine. This raises questions about the length of any immunity against the …
The number of people living in poverty in the world could increase, in comparison to the status quo in 2018, by between 85135 million under a 5 percent contraction, by between 180280 million under a 10 percent contraction, and, startlingly, …
Wearing face masks in the community is now generally accepted as highly effective in reducing disease spread. Interventions that bring moderate benefits to individuals can have large population benefits. Seatbelt wearing is one such example. The use of masks and …
COVID-19 antibody test studies are showing that about 14% have already had the disease in New York and about 5% in California. New York City and Long Island have about 20% infection rates. About 2.7 million people in the state …
Three new alphacoronaviruses, three new betacoronaviruses, and one known alphacoronavirus previously identified in other southeast Asian countries were detected for the first time in bats in Myanmar. Studies in bats in China found over 400 coronaviruses. SARS-related viruses in these …
CanSino Biologics is starting phase II clinical trials for Ad5-nCoV, a COVID-19 vaccine candidate. Ad5-nCoV is a genetic engineered vaccine candidate with the replication-defective adenovirus type 5 as the vector to express SARS-CoV-2 spike protein, which intends to be used …
The Global Initiative on Sharing All Influenza Data (GISAID) is one of the databases compiling all of the genome sequencing of COVID-19. The disease is being repeatedly sequenced to track it mutations. Genome sequencing of the disease is being done …